I n order to give the best care to patients and families, paediatricians need to integrate the highest quality scientific evidence with clinical expertise and the opinions of the family. 1 Archimedes seeks to assist practising clinicians by providing ''evidence based'' answers to common questions which are not at the forefront of research but are at the core of practice. In doing this, we are adapting a format which has been successfully developed by Kevin Macaway-Jones and the group at the Emergency Medicine Journal-''BestBets''.
A word of warning. The topic summaries are not systematic reviews, through they are as exhaustive as a practising clinician can produce. They make no attempt to statistically aggregate the data, nor search the grey, unpublished literature. What Archimedes offers are practical, best evidence based answers to practical, clinical questions.
The format of Archimedes may be familiar. A description of the clinical setting is followed by a structured clinical question. (These aid in focusing the mind, assisting searching, 2 and gaining answers. 3 ) A brief report of the search used followsthis has been performed in a hierarchical way, to search for the best quality evidence to answer the question. 4 A table provides a summary of the evidence and key points of the critical appraisal. For further information on critical appraisal, and the measures of effect (such as number needed to treat, NNT) books by Sackett 5 and Moyer 6 may help. To pull the information together, a commentary is provided. But to make it all much more accessible, a box provides the clinical bottom lines.
The electronic edition of this journal contains extra information to each of the published Archimedes topics. The papers summarised in tables are linked, by an interactive table, to more detailed appraisals of the studies. Updates to previously published topics will be linked to the original article when they are available.
Electronic-only topics that have been published on the BestBets site (www.bestbets.org) and may be of interest to paediatricians include: N Surgery or indomethacin as the treatment for symptomatic PDA in preterm infants? Readers wishing to submit their own questions-with best evidence answers-are encouraged to review those already proposed at www.bestbets.org. If your question still hasn't been answered, feel free to submit your summary according to the Instructions for Authors at www.archdischild.com. Three topics are covered in this issue of the journal. 
What do you want to do today?
Picking outcomes is extremely important. This month, we have three neonatally focused Archimedes topics. They come up with clinical bottom lines which may surprise, annoy, or bore the reader. Take the subject of lumbar punctures in neonates; performing them-or avoiding them. If you have a strong opinion about this topic it is likely to be drawn from years (well, months) of experience, seeing babies doing generally very well with/without a spinal tap, and deciding that your course of action is likely to be the most beneficial. Malbon et al argue that all babies with suspected sepsis should undergo a lumbar puncture ''to diagnose meningitis''. What if they had chosen instead to ask instead ''to prevent neuropsychological disability''? Or if they had asked whether the undertaking, or avoiding, of spinal taps makes families more or less anxious? Would the clinical bottom line be the same?
Similar suggestions can be made about our other two topics: Does improving weight gain and calorie intake matter over the short time frame of insulin infusions versus calorie restriction, or is the important outcome weight at discharge from the neonatal unit, or neurodisability at 1 year? When it comes to intubation, does data from careful studies, with practitioners primed in the use of anaesthetic agents, translate into everyday life on a neonatal unit?
We all ask specific questions, focusing on specific outcomes. It is interesting to pose slightly different questions to each query we have, to challenge our assumptions and test out different perspectives. For one clinician, diagnosing meningitis may be an important end in itself. To another, the nature of a septic episode may be far less important than the proven outcomes. The process of evidence based practice will never bring these two together, but it may make transparent where the argument should focus.
' A baby born at 28 weeks gestation initially has no respiratory disease and is breathing spontaneously in room air. On day 6 of life the baby develops increasingly frequent and severe apnoeas and episodes of bradycardia that are mostly self-limiting. In view of this, nasal continuous positive airway pressure is started, a blood culture taken, and broad spectrum antibiotics commenced. On the ward round the next morning there is a debate as to whether a lumbar puncture (LP) should also have been performed, as part of the investigations for bacterial infection. The registrar opines that this was considered, but that the baby was thought ''too unstable'' for the procedure.
If an LP is performed routinely as part of the investigations for infection, how often will it be informative? This has implications for treatment, such as the increased length of therapy or the choice of antimicrobial agent, where agents with higher CSF penetration may need to be considered. The mortality and morbidity in late onset meningitis is higher than in early onset meningitis. Blood cultures may often be negative in these babies, causing antibiotics to be discontinued too soon.
Structured clinical question
The studies are in agreement that 15-30% of babies with meningitis (CSF culture positive) have negative blood cultures. 2 Some of this may be due to the presence of viral or fungal infections, while others are due to meningitis without bacterial infection. This highlights the importance of routinely performing an LP in the investigation of late onset infection.
Except for the study by Visser and colleagues, 3 LPs were not performed routinely for investigation of infection. They were more likely to be performed if the blood cultures were positive, and even then only 60% of such babies had LPs performed. Therefore, it is likely that there is an underestimation of the prevalence of meningitis. Visser et al found that nearly one third of septic babies had coexisting meningitis. 3 Other studies, except for that of Kumar and colleagues, 4 have not investigated this proportion, though all studies showed a similar overall incidence of meningitis.
Late onset meningitis is associated with a variety of organisms, though they are predominantly Gram negative. There is a higher incidence of viral and fungal (commonly Candida albicans) organisms than in early onset infection. Episodes of group B streptococcal infection can present late and are more likely to be associated with meningitis. All studies excluded diphtheroids and Staphylococcus epidermidis as being contaminants, unless they were grown in multiple cultures and there was a clinical indication of infection.
The low rates of LP in the studies are attributed to the perceived adverse effects of the procedures, where babies are considered ''too sick to tap''. Complications that have been described in the literature include trauma, introduction of infection, spinal epidermoid tumours, brain stem herniation, and hypoxic stress for the baby. In the studies reviewed, none of the above complications were reported. 4 In the study by Stoll and colleagues there was no difference in the risk of death between infants who did and did not have an LP. 5 However, meningitis increased the risk of death substantially (23% mortality in babies with meningitis versus 9% in those who had an LP but no meningitis).
The study by Stoll and colleagues 5 found that among patients who had an LP performed, there was no significant difference across centres in the rate of positive CSF cultures (confirmed in this review). This finding suggests that, although there are LP practice differences across centres, they probably are not explained by better clinical acumen. The study also found that 10 of 90 repeat LPs grew the same organism as the original CSF culture, emphasising the importance of a repeat LP to determine that meningitis has been appropriately treated.
Although the number of babies to investigate for possible bacterial infection in order to diagnose one case of meningitis may seem high, lumbar puncture in this population seems to be safe, the treatment (intravenous antibiotics) is effective, and the event (meningitis) and the implications of missing it are potentially very serious. A 1000 g neonate develops persistent hyperglycaemia, glycosuria, and osmotic diuresis on day 2 of total parenteral nutrition. The specialist registrar decides to restrict glucose content in total parenteral nutrition (TPN).
However, the consultant disagrees and decides to start a continuous insulin infusion while administering full TPN to control blood glucose and achieve weight gain. Is the consultant's decision based on sound evidence? ELBW infants (n = 24) with hyperglycaemia were randomly assigned to receive insulin along with total parenteral nutrition (n = 12) or standard care (control; n = 12) with an aim to achieve 120 kcal/kg/day Glucose intolerance in the control infants was managed by reducing intravenous glucose administration to maintain serum glucose values ,9.9 mmol/l without glucosuria Hyperglycaemia was defined as blood glucose .9.9 mmol/l with glycosuria Commentary Hyperglycaemia occurs commonly in preterm neonates admitted to intensive care, with a reported incidence of 40-80% among VLBW (1000-1500 g) neonates.
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Hyperglycaemia usually develops when premature infants are given parenteral alimentation in amounts necessary to meet requirements for adequate growth. 7 8 It can lead to osmotic diuresis with resultant dehydration and electrolyte imbalance. 10 The subsequent hyperosmolar state has been associated with an increased risk of intraventricular haemorrhage. 11 The standard approaches to the management of hyperglycaemia in the neonate involve the use of continuous insulin infusion, glucose restriction, or both. 12 It is not clear which of these strategies is more effective in the short term control of hyperglycaemia and optimising nutrition in this vulnerable population. The resting energy expenditure in premature infants is considered to be about 60 kcal/kg/day. 13 Glucose restriction may cause caloric deprivation and lead to suboptimal postnatal growth, and in VLBW infants may retard head circumference with consequent neurodevelopmental problems. 14 15 On the other hand continuous insulin infusion may cause hypoglycaemia and hypokalaemia. Moreover, the long term clinical significance of large doses of exogenous insulin in association with early high energy intake in the preterm neonate is unknown.
In adult post-surgical and burns injury patients, uncontrolled hyperglycaemia has been associated with increased episodes of sepsis. [16] [17] [18] [19] Recent studies involving use of insulin for rigid blood glucose control in hyperglycaemic adult intensive care patients have shown significant decrease in their mortality, intensive care stay, and incidence of sepsis. 20 21 A similar study 2 in neonates has also shown a reduction in the incidence of sepsis. Studies in patients with post-myocardial infarction have also suggested an improved long term outcome in patients who received insulin and had better glycaemic control. 22 It is difficult to delineate the contribution of anabolic effects of insulin to these beneficial effects.
Fetal plasma insulin increases with gestation, largely determined by the glucose flux across the placenta. 23 At birth the disruption of placental supply of nutrients leads to a period of catabolism, and birth weight is not usually recovered until 7-10 days of age. The blood glucose levels during this period are maintained by gluconeogenesis and glycolysis driven by counter regulatory hormones such as catecholamines, growth hormone, and cortisol, diverting glucose utilisation from muscle to brain. The very high blood sugar levels in the first few weeks of life may therefore reflect insulin resistance and/or relative insulin deficiency. The practice of early TPN may also increase the likelihood of hyperglycaemia. 24 Administration of intravenous fat emulsion has been shown to increase plasma glucose concentration by 24% over baseline values. 25 An additive effect has been noted when glucose and amino acids were added to the intravenous fat emulsion. 26 In contrast the establishment of oral feeds and the coupling of food related nutrient and hormonal signals increase the release of insulin. [27] [28] [29] However, in the VLBW infants it may not be possible to initiate oral feeding and thus induce normal insulin secretion. This leads to prolongation of the catabolic state and as a consequence birth weight may not be regained for several weeks. Fetal growth restriction in animal models has been shown to be associated with impaired pancreatic development and a reduced b-cell mass, 30 31 which may have long term implications. Insulin replacement during this catabolic neonatal period may potentially limit proteolysis, 32 and improve anabolism and weight gain. Furthermore, improved glycaemic control may help reduce the risk of sepsis and intraventricular haemorrhage.
The literature search yielded six relevant trials of insulin therapy; two controlled trials, and one case series in extremely low birth weight (ELBW, ,1000 g) infants, and three case series in VLBW infants (,1500 g).
Two controlled studies 1 2 compared insulin therapy to reduction in glucose intake. The study by Meetze and colleagues 1 showed improved glycaemic control without hypoglycaemia and significantly shorter duration to reach resting energy expenditure of 60 kcal/kg/day. It remains to be elucidated whether such short term benefits confer any long term advantages. Collins and colleagues 2 showed improved glycaemic control, increased calorie intake and weight gain, and decreased incidence of sepsis in the insulin group. However, the glucose delivery rates were much higher than common practise.
All uncontrolled studies except that of Binder and colleagues 3 reported improved glycaemic control, and increased caloric intake and weight gain on insulin therapy. However, all studies except Meetze and colleagues 1 and Ostertag and colleagues 5 reported episodes of hypoglycaemia ranging from 0.2% to 2.8% of all observations in the insulin group. The further exploration of both side effects and the population to consider use of insulin infusions is complicated by the marked variation between studies regarding the definition of hyperglycaemia and hypoglycaemia (see table 3 ).
CLINICAL BOTTOM LINE
N Insulin therapy in the hyperglycaemic ELBW infant improves blood glucose control, caloric intake, and probably weight gain. It is not clear whether this confers any long term advantage. (Grade B) N Insulin therapy in the hyperglycaemic VLBW infant between 1000 and 1500 g is difficult to evaluate due to lack of good quality studies in this weight category. A neonate on the intensive care unit requires semiurgent intubation. As the procedure is being carried out, the medical student notices that the neonate is struggling, prolonging the procedure, and appears to be in distress. The medical student asks why no medication was given before the neonate was intubated as this is the procedure in adults and children. Medline search found 459 papers, of which 12 were relevant and of a sufficient quality to be included in the paper.
Structured clinical question
Embase search found a further one paper. Cinahl found no further papers. Two further relevant papers were found by searching through the references from the papers found.
All three databases were searched again combining the above search strategy with [AND {exp pain or pain.mp.}]. No further papers were identified.
See table 4.
Commentary
Intubation is a potentially painful and distressing procedure. It is suggested that such physiological distress may increase neonatal morbidity. Premedication for intubation with potent opiates or anaesthetic agents and muscle relaxants is the routine for children and infants. Premedication is not common practice for the intubation of neonates; Whyte et al in 1998 revealed that only 14% of the UK's neonatal units had a written policy for premedication for semi-urgent or elective intubation. Only 37% of the neonatal units surveyed routinely used sedation prior to intubation, and those that did used drug doses that varied by factors up to 200. 16 Premedication is more commonly used for term rather than preterm neonates. [16] [17] [18] Recent research and debate has focused on whether premedication of the neonate for a routine semi-urgent intubation (that is, when intravenous access is available and difficult intubation is not expected) may be safer and a more effective method than awake intubation.
From the available evidence it is clear that awake intubation is associated with a significantly higher intracranial pressure, 5 8 10-13 higher blood pressure, 3 7 11 and more variable heart rate 2 3 5 12 than premedicated intubation. In addition, the increased time taken to intubate 2-4 6 7 and the greater number of attempts associated with awake intubation 2 4 6 may compound these factors and lead to increased morbidity. Studies using thiopentone show significantly lower intracranial pressure, significantly more stable heart rate, and lower blood pressure; fewer attempts to intubate are needed and the time taken to intubate is shorter in neonates premedicated with thiopentone than in 3-5 10 Studies using opiates show a significantly lower blood pressure and shorter duration of hypoxia during intubation, and shorter length of time taken to intubate with a potent opiate than in control neonates. 6 7 They also show that morphine and pethidine are not the drugs of choice. 1 6 This is likely to be due to their variable pharmacokinetics and pharmacodynamics in neonates. 16 Muscle relaxant studies show a significantly lower intracranial pressure, improved cerebral perfusion pressure, less heart rate variability, and a shorter time needed to intubate in neonates premedicated with a muscle relaxant than in control neonates. 7 8 12 13 Chest wall rigidity was reported in three of seven neonates given fentanyl without a muscle relaxant in one randomised controlled trial, 7 and in four neonates in one cohort study, resolving with suxamethonium in three cases and self limiting in the other.
14 No other studies reported this adverse event when an opiate is used with a muscle relaxant.
Current evidence suggests that for routine semi-urgent intubation of neonates, the use of premedication is a more effective technique, with less potentially harmful physiological fluctuations, than traditional awake intubation. N More clinical trials are required to determine the optimal premedication strategy. 
